16th Life Sciences Accounting & Reporting Congress 2020 | CBI | 16 March 2020 | Loews Hotel, Philadelphia, 1200 Market St, Philadelphia, PA 19107, US

The industry’s event of the year for CPE education, networking and peer benchmarking, CBI’s 16th Life Sciences Accounting & Reporting Congress drives practice alignment and business strategy. As the marketplace increases in complexity and technical standards change, Pharma/Biotech/Device Finance and Accounting leaders must stay ahead on regulations and trends. The Congress convenes over 100 speakers and over 500 attendees each year, with over 90% of the audience noting the event as a valuable must-attend meeting!

2020 Speakers

Amit Agarwal
Managing Director, Deloitte Consulting

Mike Banish
Senior Manager, Ernst & Young LLP

Angela Barcelos
Risk Advisory Leader, CFGI

Silvia Bassily
Senior Manager, Deloitte & Touche LLP

Graeme Bell
Chief Financial Officer, Tmunity Therapeutics

Eric Bowlin
Partner, Deloitte & Touche LLP

Erik Bradbury
Partner, Ernst & Young

Kary Callahan
Associate Director, Commercial Finance, Paratek Pharmaceuticals

Scott Charles
Chief Financial Officer, Cytel

John Charters
Partner, PwC

Kyle Cheney
Partner, Deloitte & Touche LLP

Stephan Choe
Partner, Ernst & Young LLP

Andreas Chrysostomou
Managing Director, Global Leader – Healthcare Life Sciences Industry, Duff & Phelps

Chad Cohen
Chief Financial Officer, Adaptive Biotechnologies Corp

Gina Consylman
Chief Financial Officer, Ironwood Pharmaceuticals

Patrick Coyle
Chief Financial Officer, Eisai

Jack Crowley
Chief Financial Officer, PGDx, Inc.

John Crowley
Chief Financial Officer, Fusion Pharmaceuticals

Brent Danner
Director, Business Analysis, Eli Lilly & Co

Christine Davine
National Managing Partner - Quality, Risk and Regulatory, Deloitte & Touche LLP

Bob Decker
Vice President, Corporate Controller and Chief Accounting Officer, Johnson & Johnson

Neil Dimick
Chair of Mylan’s Audit Committee; Member of Mylan’s Executive and Finance Committees; Former Chief Financial Officer, AmerisourceBergen Corporation

James Dolan
Senior Manager, Ernst & Young LLP

Ryan Dolan
Partner, CFGI

Barbara Duncan
Biotech Board Member; Former Chief Financial Officer, Intercept Pharmaceuticals, Inc.

David Elkins
Executive Vice President and Chief Financial Officer, Bristol-Myers Squibb

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader, Deloitte & Touche LLP

Trevor Flaxman
Netsuite Consultant for Life Sciences, Sikich

Jon Freve
Chief Financial Officer, Springbank Pharmaceuticals

Jenny Gilmore
Managing Director, Deloitte & Touche LLP

Dan Goldstein
Vice President and Corporate Controller, Haemonetics

Tim Gordon
FAAS Global Health Sciences & Wellness Leader, Ernst & Young LLP

Tim Gordon, FAAS
Global Health Sciences & Wellness Leader, Ernst & Young LLP

Melissa Hackel
Vice President of Finance, Infinity Pharmaceuticals

Chris Haro
Senior Manager, US Business Operations Consolidation Finance, Amgen Inc

Rich Holtz
Senior Manager, Deloitte & Touche LLP

Phil Howard
Partner, Ernst & Young LLP

Marsha Hunt
Board Member, FASB

Rita Karachun
Senior Vice President and Global Controller, Merck

Larry Kocot
Principal and National Leader, KPMG Center for Healthcare Regulatory Insight, KPMG

Philip Koesters
Senior Director of Accounting, Sunovion Pharmaceuticals

Robin C. Kramer
Vice President, Chief Accounting Officer, Biogen Inc.

Chris Krawtschuk
SVP Head of Finance / U.S. CFO & Treasurer of the U.S. Board of Directors, MorphoSys AG

Rakhi Kumar
Chief Accounting Officer, Roivant Sciences

Arvind Kush
Managing Director, Healthcare Investment Banking, Bank of America Merrill Lynch

Sharon Langan
Global Practice Leader, Life Sciences, Informa Connect-CBI

Michael Lombardo
Partner, Deloitte & Touche LLP

Chris Lucas
Executive Director, Global Financial Planning & Analysis, Amicus Therapeutics

Daniel Lujan
Senior Manager, Assurance Services, Ernst & Young LLP

Kelly MacDonald
Chief Accounting Officer and Vice President of Finance, Ironwood Pharmaceuticals

Michael Makovec
Partner, Deloitte & Touche LLP

Michael Mason
Chief Financial Officer, Karyopharm

Peter Micca
Partner, Life Sciences and Health Care; National Audit and Assurance Health Tech Leader, Deloitte & Touche LLP

Savi Mittal
Senior Manager, Ernst & Young LLP

Melanie Morel-Ferris
Controller, Akcea Therapeutics

Funso Olufade
Director, US Commercial Finance, Amicus Therapeutics Inc.

Robert Owens
Vice President and Chief Accountant, Bristol-Myers Squibb

Paris Panayiotopoulos
Managing Director, Blackstone Life Sciences

Viq Pervaaz
Partner, People Advisory Services, Ernst & Young LLP

Kelly Provost
Managing Director, CFGI

Paul Ricci
Partner, Technology and Data National Leader, CohnReznick

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson

Michelle Robertson
Chief Financial Officer, Editas Medicine

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader, PwC

Tara Ruggeri
Head, North America Technical Accounting, Sanofi US

Nikhil Rupani
Partner, PwC

Aradhana Sarin
Executive Vice President and Chief Financial Officer, Alexion Pharmaceuticals Inc.

Carolyn Selig
Partner, Deloitte & Touche LLP

Shurjo Sen
Partner, PwC

Gary Sender
Chief Financial Officer, Nabriva Therapeutics

Jennifer Sharpe
Executive Advisor, Life Sciences Revenue Analytics Collaborative, IntegriChain

Bobby Shuman
Partner, PwC

John Sichak
Partner, PwC

Marc Siegel
Partner, Ernst & Young LLP

Alex Smith
Partner, Deloitte & Touche LLP

Tom Smith
Vice President, Corporate and Financial Strategy, Dicerna Pharmaceuticals

Manmeet Soni
Chief Financial Officer, Reata Pharmaceuticals, Inc.

Corey Sparks
Vice President of Finance and Controller – North America, Teva Pharmaceuticals

Thomas Spoerel
Vice President of Finance and Controller, BD

Vladimir Starkov, PhD
Director, Nera Consulting

Evan Sussholz
Partner, Transaction Advisory Services, Ernst & Young LLP

Michael Tannenbaum
Chief Financial Officer, Brex Inc

Vinay Torani
Managing Director, PwC

Gerardo Ubaghs
Director, Global Healthcare Investment Banking, BAML

Kaitlin Valenti
Director, PwC

Jeroen Van Paassen
Partner, PwC

Erica Vandell-DeMarco
Director, The Siegfried Group, LLP

John Vanosdall
Deputy Chief Accountant, U.S. Securities & Exchange Commission

Kevin Vaughn
Accounting Branch Chief, Office of Life Sciences, U.S. Securities & Exchange Commission

Zachary Weisbly
Director, PwC

Robert Wells
Managing Director, CFGI

Mary Wilcox
Chief Accounting Officer, Medtronic

Pamela Yanakopulos
Partner, Capital Markets & Accounting Advisory Services, PwC

Karen Young
US Pharmaceutical and Life Sciences Leader, PwC

2020 Sponsors and Partners

LEAD SPONSORS:
• PwC
• Deloitte
• EY
• CFGI

ADDITIONAL SPONSORS:
• Sikich
• KPMG LLP
• REAL Software Systems
• Duff & Phelps
• Adaptalogix
• IntegriChain
• Brex
• FloQast
• Bank of America
• The Siegfried Group
• NERA Economic Consulting
• Riparian
• CohnReznick
• Empire Valuation
• Centri
• Oversight

MEDIA PARTNERS:
• Pharmaceutical Executive
• PharmaVOICE
• Drug Channels
• Pharmaceutical Commerce
• HealthEconomics.Com